Eagle Pharmaceuticals plans to price initial public offering of stock

Piper Jaffray and William Blair will be the joint bookrunning managers

By Devika Patel

Knoxville, Tenn., Dec. 20 - Eagle Pharmaceuticals, Inc. will conduct an initial public offering of its common stock with a 30-day greenshoe option, according to a Form S-1 filed Friday with the Securities and Exchange Commission.

Piper Jaffray and William Blair are the joint bookrunners. Cantor Fitzgerald & Co. is the co-manager.

Proceeds will be used for research and development, sales and marketing, working capital and general corporate purposes.

The specialty pharmaceutical company is based in Woodcliff Lake, N.J. It expects to list its common stock on an exchange under the symbol "EGRX."

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.